Advertisement
American Journal of Kidney Diseases

Incident Atrial Fibrillation and the Risk of Congestive Heart Failure, Myocardial Infarction, End-Stage Kidney Disease, and Mortality Among Patients With a Decreased Estimated GFR

Published:November 16, 2017DOI:https://doi.org/10.1053/j.ajkd.2017.08.016

      Background

      The association of atrial fibrillation (AF), estimated glomerular filtration rate (eGFR), and adverse events remains unknown.

      Study Design

      Population-based retrospective cohort study from Ontario, Canada.

      Setting & Participants

      1,422,978 adult residents with eGFRs < 90 mL/min/1.73 m2 from April 1, 2006, through March 31, 2015.

      Factor

      A diagnosis of AF at hospitalization.

      Outcomes

      Congestive heart failure (CHF), myocardial infarction (MI), end-stage kidney disease, all-cause mortality.

      Results

      All adverse events were more frequent in individuals with AF (93,414 propensity score matched) compared to no AF, and this difference was more pronounced within the first 6 months of the index date (CHF: 3.04% [AF] vs 0.28% [no AF], subdistribution HR [sHR] of 11.57 [95% CI, 10.26-13.05]; MI: 0.97% [AF] vs 0.21% [no AF], sHR of 4.76 [95% CI, 4.17-5.43]; end-stage kidney disease: 0.16% [AF] vs 0.03% [no AF], sHR of 5.84 [95% CI, 3.82-8.93]; and all-cause mortality: 6.11% [AF] vs 2.50% [no AF], HR of 2.62 [95% CI, 2.50-2.76]) than in the period more than 6 months after the index date (CHF: 6.87% [AF] vs 2.87% [no AF], sHR of 2.64 [95% CI, 2.55-2.74]; MI: 2.21% [AF] vs 1.81% [no AF], sHR of 1.24 [95% CI, 1.18-1.30]; end-stage kidney disease: 0.52% [AF] vs 0.32% [no AF], sHR of 1.75 [95% CI, 1.57-1.95]; and all-cause mortality: 15.55% [AF] vs 15.10% [no AF], HR of 1.07 [95% CI, 1.04-1.10]). The results accounted for the competing risk for mortality. eGFR level modified the effect of AF on CHF (P for interaction < 0.05).

      Limitations

      Observational study design does not permit determination of causality; only a single outpatient eGFR measure was used; medication data were not included.

      Conclusions

      Incident AF is associated with a high risk for adverse outcomes in patients with eGFRs < 90 mL/min/1.73 m2. Because the risk is exceedingly high within the first 6 months after AF diagnosis, therapeutic interventions and monitoring may improve outcomes.

      Graphical Abstract

      Index Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Kidney Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Coresh J.
        • Astor B.C.
        • Greene T.
        • Eknoyan G.
        • Levey A.S.
        Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey.
        Am J Kidney Dis. 2003; 41: 1-12
        • Coresh J.
        • Byrd-Holt D.
        • Astor B.C.
        • et al.
        Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000.
        J Am Soc Nephrol. 2005; 16: 180-188
        • Coresh J.
        • Selvin E.
        • Stevens L.A.
        • et al.
        Prevalence of chronic kidney disease in the United States.
        JAMA. 2007; 298: 2038-2047
        • Jha V.
        • Garcia-Garcia G.
        • Iseki K.
        • et al.
        Chronic kidney disease: global dimension and perspectives.
        Lancet. 2013; 382: 260-272
        • Go A.S.
        • Yang J.
        • Ackerson L.M.
        • et al.
        Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure - the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.
        Circulation. 2006; 113: 2713-2723
        • Anavekar N.S.
        • McMurray J.J.
        • Velazquez E.J.
        • et al.
        Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.
        N Engl J Med. 2004; 351: 1285-1295
        • Go A.S.
        • Chertow G.M.
        • Fan D.
        • McCulloch C.E.
        • Hsu C.
        Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.
        N Engl J Med. 2004; 351: 1296-1305
        • Ananthapanyasut W.
        • Napan S.
        • Rudolph E.H.
        • et al.
        Prevalence of atrial fibrillation and its predictors in nondialysis patients with chronic kidney disease.
        Clin J Am Soc Nephrol. 2010; 5: 173-181
        • Alonso A.
        • Lopez F.L.
        • Matsushita K.
        • et al.
        Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) Study.
        Circulation. 2011; 123: 2946-2953
        • Horio T.
        • Iwashima Y.
        • Kamide K.
        • et al.
        Chronic kidney disease as an independent risk factor for new-onset atrial fibrillation in hypertensive patients.
        J Hypertens. 2010; 28: 1738-1744
        • Iguchi Y.
        • Kimura K.
        • Kobayashi K.
        • et al.
        Relation of atrial fibrillation to glomerular filtration rate.
        Am J Cardiol. 2008; 102: 1056-1059
        • Baber U.
        • Howard V.J.
        • Halperin J.L.
        • et al.
        Association of chronic kidney disease with atrial fibrillation among adults in the United States REasons for Geographic and Racial Differences in Stroke (REGARDS) study.
        Circ Arrhythmia Electrophysiol. 2011; 4: 26-32
        • Nelson S.E.
        • Shroff G.R.
        • Li S.
        • Herzog C.A.
        Impact of chronic kidney disease on risk of incident atrial fibrillation and subsequent survival in Medicare patients.
        J Am Heart Assoc. 2012; 1: 1-10
        • Soliman E.Z.
        • Prineas R.J.
        • Go A.S.
        • et al.
        Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC).
        Am Heart J. 2010; 159: 1102-1107
        • Go A.S.
        • Hylek E.M.
        • Phillips K.A.
        • et al.
        Prevalence of diagnosed atrial fibrillation in adults.
        JAMA. 2001; 285: 2370-2375
        • Chugh S.S.
        • Havmoeller R.
        • Narayanan K.
        • et al.
        Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study.
        Circulation. 2014; 129: 837-847
        • Miyasaka Y.
        • Barnes M.E.
        • Gersh B.J.
        • et al.
        Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence.
        Circulation. 2006; 114: 119-125
        • Thrall G.
        • Lane D.
        • Carroll D.
        • Lip G.Y.
        Quality of life in patients with atrial fibrillation: a systematic review.
        Am J Med. 2006; 119 (e1-e19): 448
        • Kim M.H.
        • Johnston S.S.
        • Chu B.-C.
        • Dalal M.R.
        • Schulman K.L.
        Estimation of total incremental health care costs in patients with atrial fibrillation in the United States.
        Circ Cardiovasc Qual Outcomes. 2011; 4: 313-320
        • Levey A.S.
        • Stevens L.A.
        • Schmid C.H.
        • et al.
        A new equation to estimate glomerular filtration rate.
        Ann Intern Med. 2009; 150: 604-612
        • Kannel W.B.
        • Wolf P.A.
        • Benjamin E.J.
        • Levy D.
        Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates.
        Am J Cardiol. 1998; 82: 2N-9N
        • Wolf P.A.
        • Abbott R.D.
        • Kannel W.B.
        Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.
        Stroke. 1991; 22: 983-988
        • Wolf P.A.
        • Dawber T.R.
        • Thomas H.E.
        • Kannel W.B.
        Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study.
        Neurology. 1978; 28: 973-977
        • Miyasaka Y.
        • Barnes M.E.
        • Gersh B.J.
        • et al.
        Incidence and mortality risk of congestive heart failure in atrial fibrillation patients: a community-based study over two decades.
        Eur Heart J. 2006; 27: 936-941
        • Schnabel R.B.
        • Rienstra M.
        • Sullivan L.M.
        • et al.
        Risk assessment for incident heart failure in individuals with atrial fibrillation.
        Eur J Heart Fail. 2013; 15: 843-849
        • Santhanakrishnan R.
        • Wang N.
        • Larson M.G.
        • et al.
        Atrial fibrillation begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction.
        Circulation. 2016; 133: 484-492
        • Soliman E.Z.
        • Lopez F.
        • O’Neal W.T.
        • et al.
        Atrial fibrillation and risk of ST-segment-elevation versus non-ST-segment-elevation myocardial infarction: the Atherosclerosis Risk in Communities (ARIC) study.
        Circulation. 2015; 131: 1843-1850
        • Soliman E.Z.
        • Safford M.M.
        • Muntner P.
        • et al.
        Atrial fibrillation and the risk of myocardial infarction.
        JAMA Intern Med. 2014; 174: 107-114
        • Watanabe H.
        • Watanabe T.
        • Sasaki S.
        • Nagai K.
        • Roden D.M.
        • Aizawa Y.
        Close bidirectional relationship between chronic kidney disease and atrial fibrillation: the Niigata preventive medicine study.
        Am Heart J. 2009; 158: 629-636
        • Bansal N.
        • Hsu C.-Y.
        • Go A.S.
        Intersection of cardiovascular disease and kidney disease: atrial fibrillation.
        Curr Opin Nephrol Hypertens. 2014; 23: 275-282
        • Winkelmayer W.C.
        • Patrick A.R.
        • Liu J.
        • Brookhart M.A.
        • Setoguchi S.
        The increasing prevalence of atrial fibrillation among hemodialysis patients.
        J Am Soc Nephrol. 2011; 22: 349-357
        • Wetmore J.B.
        • Mahnken J.D.
        • Rigler S.K.
        • et al.
        The prevalence of and factors associated with chronic atrial fibrillation in Medicare/Medicaid-eligible dialysis patients.
        Kidney Int. 2012; 81: 469-476
        • Genovesi S.
        • Vincenti A.
        • Rossi E.
        • et al.
        Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients.
        Am J Kidney Dis. 2008; 51: 255-262
        • Genovesi S.
        • Pogliani D.
        • Faini A.
        • et al.
        Prevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patients.
        Am J Kidney Dis. 2005; 46: 897-902
        • Wizemann V.
        • Tong L.
        • Satayathum S.
        • et al.
        Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy.
        Kidney Int. 2010; 77: 1098-1106
        • Bansal N.
        • Fan D.
        • Hsu C.-Y.
        • Ordonez J.D.
        • Marcus G.M.
        • Go A.S.
        Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease.
        Circulation. 2013; 127: 569-574
        • Bansal N.
        • Xie D.
        • Tao K.
        • et al.
        Atrial fibrillation and risk of ESRD in adults with CKD.
        Clin J Am Soc Nephrol. 2016; 11: 1189-1196
        • Olesen J.B.
        • Lip G.Y.H.
        • Kamper A.L.
        • et al.
        Stroke and bleeding in atrial fibrillation with chronic kidney disease.
        N Engl J Med. 2012; 367: 625-635
        • Garg A.X.
        • Mamdani M.
        • Juurlink D.N.
        • van Walraven C.
        Identifying individuals with a reduced GFR using ambulatory laboratory database surveillance.
        J Am Soc Nephrol. 2005; 16: 1433-1439
        • Jensen P.N.
        • Johnson K.
        • Floyd J.
        • Heckbert S.R.
        • Carnahan R.
        • Dublin S.
        Identifying atrial fibrillation from electronic medical data: a systematic review.
        Pharmacoepidemiol Drug Saf. 2012; 21: 141-147
        • Austin P.C.
        Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research.
        Commun Stat Simul Comput. 2009; 38: 1228-1234
        • Fine J.P.
        • Gray R.J.
        A proportional hazards model for the subdistribution of a competing risk.
        J Am Stat Assoc. 1999; 94: 496-509
        • Pandey A.
        • Gersh B.J.
        • McGuire D.K.
        • et al.
        Association of body mass index with care and outcomes in patients with atrial fibrillation: results from the ORBIT-AF Registry.
        JACC Clin Electrophysiol. 2016; 2: 355-363
        • Wang T.J.
        • Larson M.G.
        • Levy D.
        • et al.
        Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study.
        Circulation. 2003; 107: 2920-2925
        • Healey J.S.
        • Oldgren J.
        • Ezekowitz M.
        • et al.
        Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study.
        Lancet. 2016; 388: 1161-1169
        • Khazanie P.
        • Liang L.
        • Qualls L.G.
        • et al.
        Outcomes of Medicare beneficiaries with heart failure and atrial fibrillation.
        JACC Heart Fail. 2014; 2: 41-48
        • Bansal N.
        • Fan D.
        • Hsu C.Y.
        • Ordonez J.D.
        • Go A.S.
        Incident atrial fibrillation and risk of death in adults with chronic kidney disease.
        J Am Heart Assoc. 2014; 3: e001303
        • Upadhyay A.
        • Larson M.G.
        • Guo C.Y.
        • et al.
        Inflammation, kidney function and albuminuria in the Framingham Offspring cohort.
        Nephrol Dial Transplant. 2011; 26: 920-926
        • Gupta J.
        • Mitra N.
        • Kanetsky P.A.
        • et al.
        Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC.
        Clin J Am Soc Nephrol. 2012; 7: 1938-1946
        • Amdur R.L.
        • Mukherjee M.
        • Go A.
        • et al.
        Interleukin-6 is a risk factor for atrial fibrillation in chronic kidney disease: findings from the CRIC study.
        PLoS One. 2016; 11: e0148189
        • Anderson J.L.
        • Allen Maycock C.A.
        • Lappé D.L.
        • et al.
        Frequency of elevation of C-reactive protein in atrial fibrillation.
        Am J Cardiol. 2004; 94: 1255-1259
        • Mukamal K.J.
        • Tolstrup J.S.
        • Friberg J.
        • Grønbaek M.
        • Jensen G.
        Fibrinogen and albumin levels and risk of atrial fibrillation in men and women (the Copenhagen City Heart Study).
        Am J Cardiol. 2006; 98: 75-81
        • Friedrichs K.
        • Klinke A.
        • Baldus S.
        Inflammatory pathways underlying atrial fibrillation.
        Trends Mol Med. 2011; 17: 556-563
        • Gutiérrez O.M.
        • Januzzi J.L.
        • Isakova T.
        • et al.
        Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease.
        Circulation. 2009; 119: 2545-2552
        • Faul C.
        • Amaral A.P.
        • Oskouei B.
        • et al.
        FGF23 induces left ventricular hypertrophy.
        J Clin Invest. 2011; 121: 4393-4408
        • Drazner M.H.
        The progression of hypertensive heart disease.
        Circulation. 2011; 123: 327-334
        • Charytan D.M.
        • Shelbert H.R.
        • Di Carli M.F.
        Coronary microvascular function in early chronic kidney disease.
        Circ Cardiovasc Imaging. 2010; 3: 663-671
        • Stehouwer C.D.
        • Smulders Y.M.
        Microalbuminuria and risk for cardiovascular disease: analysis of potential mechanisms.
        J Am Soc Nephrol. 2006; 17: 2106-2111
        • Imamura S.
        • Hirata K.
        • Orii M.
        • et al.
        Relation of albuminuria to coronary microvascular function in patients with chronic kidney disease.
        Am J Cardiol. 2014; 113: 779-785
        • Kato S.
        • Saito N.
        • Kirigaya H.
        • et al.
        Impairment of coronary flow reserve evaluated by phase contrast cine-magnetic resonance imaging in patients with heart failure with preserved ejection fraction.
        J Am Heart Assoc. 2016; 5: 1-9
        • Molnar A.O.
        • Bota S.E.
        • Garg A.X.
        • et al.
        The risk of major hemorrhage with CKD.
        J Am Soc Nephrol. 2016; 27: 2825-2832